Phase 1 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with Retinal Disease due to MERTK Mutations
عنوان الدراسة
Phase 1 Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients with Retinal Disease due to MERTK Mutations
داعم الدراسة
PSCDR
دواء الدراسة
rAAV2
رقم بروتوكول الدراسة
rAAV2-VMD2-hMERTK
حالة الدراسة
Completed
موقع الدراسة
KFSH & RC-R
مرحلة الدراسة
1
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.